Key result
Lower Sirt1 levels early in life are associated with premature microvascular dysfunction during adulthood and a potentially higher risk of developing cardiovascular disease.
Why the study?
Are lower Sirt1 levels during childhood associated with premature microvascular dysfunction later in life?
Cohort
Are lower Sirt1 levels during childhood associated with premature microvascular dysfunction later in life?
Lower Sirt1 levels in childhood are associated with premature microvascular dysfunction in adulthood, suggesting Sirt1 as a potential therapeutic target for cardiovascular disease prevention.
Answers are grounded in this paper and cite their sources.
Early Sirt1 assessment should not yet inform practice; leaves open its role as a therapeutic target in vascular aging.
With a longitudinal cohort, novel observations from the present study demonstrate that individuals who had lower Sirt1 early in life exhibit premature microvascular dysfunction during adulthood and may be at higher risk to develop CVD. These results provide experimental evidence that Sirt1 may play an important role in microvascular function with age and represent a potential therapeutic target to prevent premature vascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Rodriguez‐Miguelez et al. (2020) conducted a cohort in Microvascular dysfunction. Lower Sirt1 early in life was evaluated on Premature microvascular dysfunction during adulthood. Lower Sirt1 levels early in life are associated with premature microvascular dysfunction during adulthood and a potentially higher risk of developing cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: